Stocktoria
Kyverna Therapeutics, Inc. KYTX
Nasdaq · stock · Biological Products, (No Diagnostic Substances) · website · IPO 2024-02-08
Kyverna Therapeutics, Inc. institutional holders
| Investor | Shares | Value | % of company |
|---|---|---|---|
| BlackRock Finance, Inc. | 1,453,667 | $10.9M | 2.41% |
| MILLENNIUM MANAGEMENT LLC | 639,780 | $5.7M | 1.06% |
| D. E. Shaw & Co., Inc. | 469,346 | $4.2M | 0.78% |
| RENAISSANCE TECHNOLOGIES LLC | 333,899 | $3.0M | 0.55% |
| CITADEL ADVISORS LLC | 321,927 | $2.9M | 0.53% |
| TWO SIGMA INVESTMENTS, LP | 51,319 | $457,252 | 0.08% |
% of company = reported institutional shares ÷ shares outstanding. Based on the latest reports; not every holder reports every quarter.
Computed from company filings · US · as of 2025-12-31. Facts plus Stocktoria's own computed scores — not investment advice.